Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in a Rural Community in Western Kenya during the First 24 Months of the Coronavirus Disease 2019 Pandemic
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.25-0240 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Daja D Gaston und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, COVID-19, Antibodies, Viral, SARS-CoV-2. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Seroreactivity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens was commonly reported in African settings during the early stages of the coronavirus disease 2019 pandemic. Severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (nAbs) are not only correlated with functional protection from disease but also are highly specific responses to the virus. These responses were used to investigate the evolution of virus exposure in a community-based, longitudinal cohort of 504 individuals in rural Western Kenya. Eluates from dried blood spots collected every 3 months from January 2020 to September 2021 were tested for nAbs using a commercial kit. Only 10 individuals developed SARS-CoV-2 nAbs, all of which were clustered in December 2020 (wildtype virus) and September 2021 (delta variant). After seroconversion, all patients seroreverted within 2 months. Despite reports of widespread viral exposure in Western Kenya from 2020 to 2021, the paucity of nAbs highlights the limited natural immunity present when vaccines became available in late 2021 in Kenya.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, School of Medicine, Duke University, Durham, North Carolina.
- Duke Global Health Institute, Duke University, Durham, North Carolina.
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
- School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.
- School of Public Health, College of Health Sciences, Moi University, Eldoret, Kenya.
Förderung
- NIAID NIH HHS
Zitieren
APA
Gaston, D. D., Markwalter, C. F., Grassia, J. T., Freedman, B., Wang, L. F., Obala, A. A., O'Meara, W. P., & Taylor, S. M. (2025). Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in a Rural Community in Western Kenya during the First 24 Months of the Coronavirus Disease 2019 Pandemic. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0240
Vancouver
Gaston DD, Markwalter CF, Grassia JT, Freedman B, Wang LF, Obala AA, et al. Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in a Rural Community in Western Kenya during the First 24 Months of the Coronavirus Disease 2019 Pandemic. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.25-0240
BibTeX
@article{Gaston2025,
author = {Gaston, Daja D and Markwalter, Christine F and Grassia, Jillian T and Freedman, Betsy and Wang, Lin-Fa and Obala, Andrew A and O'Meara, Wendy P and Taylor, Steve M},
title = {Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in a Rural Community in Western Kenya during the First 24 Months of the Coronavirus Disease 2019 Pandemic},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.25-0240}
}
EUVIMED